Metabolism May Predict Stress Responses Differently in Male and Female Mice

A new study published in Translational Psychiatry examines how metabolic profiles in the blood may forecast how adult mice respond to stress, and, crucially, how those metabolic signals differ between males and females. The research, conducted in adult C57Bl/6 mice, one of the most widely used strains in biomedical research, adds to a growing body of evidence that biological sex shapes not only the magnitude of an animal’s stress response but also the biochemical fingerprints that precede and accompany it. The findings carry implications for how preclinical stress research is designed and interpreted, and for the search biomarkers that could eventually translate into clinical practice.

Stress responses in mammals involve a tightly coordinated cascade spanning the hypothalamic-pituitary-adrenal, or HPA, axis, the sympathetic nervous system, and a wide array of peripheral tissues. When an animal perceives a threat, the hypothalamus signals the pituitary gland, which in turn prompts the adrenal glands to release glucocorticoids such as corticosterone in rodents. This hormonal surge mobilizes energy: glucose is released from the liver, free fatty acids are liberated from adipose tissue, and metabolic flux is redirected toward tissues needed for fight or flight. Because stress and metabolism are so deeply intertwined, circulating metabolites offer a dynamic readout of how an organism is coping with a stressor, and potentially a way to predict vulnerability before overt behavioral symptoms appear.

Metabolomics, the systematic measurement of small molecules in biological samples, has become an increasingly popular tool in neuroscience and psychiatric research for precisely this reason. Unlike genomics, which captures static genetic risk, or transcriptomics, which reflects gene expression at a single moment, the metabolome provides a near-real-time snapshot of physiology. By profiling hundreds of metabolites including amino acids, lipids, carbohydrates, and energy-related intermediates, researchers can identify patterns that distinguish resilient animals from susceptible ones, or that track the trajectory of recovery after a stressful experience. The new work applies this logic to a deceptively simple question: can we look at a mouse’s metabolic state and anticipate how it will respond to stress?

A central motivation for the study is the well-documented observation that males and females often respond differently to stressors. In rodents, females frequently show more pronounced and prolonged corticosterone responses to acute stressors such as restraint, while males in some paradigms display stronger behavioral sensitization to chronic stress. These differences have been observed across behavioral, endocrine, and neural measures, and they complicate efforts to develop biomarkers that generalize across the sexes. Historically, many preclinical studies relied almost exclusively on male animals, a practice that left female physiology understudied and contributed to failed translations when candidate drugs and biomarkers moved into mixed-sex human populations. Including both sexes and analyzing them separately has therefore become both a regulatory expectation and a scientific necessity.

The C57Bl/6 inbred strain provides a controlled backdrop for this question. Because all animals share a nearly identical genetic background, differences in stress responses and metabolic profiles among individuals within a sex can be attributed largely to environmental experience, developmental history, and stochastic physiological variation rather than genetic diversity. This makes the strain an ideal system for isolating the contribution of biological sex to the relationship between metabolism and stress. It also means that findings from C57Bl/6 mice can be compared against a vast existing literature, since the strain has been the workhorse of behavioral neuroscience for decades and its stress phenotypes are extensively characterized.

Although the full article text underlying this report was not accessible in the supplied source material, the study’s framing within Translational Psychiatry situates it in a field actively seeking objective, biologically grounded measures of stress-related vulnerability. Translational psychiatry research typically aims to bridge laboratory findings in animal models and clinical observations in patients with stress-related disorders such as major depression, post-traumatic stress disorder, and anxiety conditions. Metabolic biomarkers are attractive candidates in this context because they can be measured in humans with the same analytic platforms used in mice, opening a pathway for cross-species validation. Lipid profiles, amino acid ratios, and markers of mitochondrial energy metabolism have all been implicated in human depression and chronic stress, making them plausible targets for a predictor-focused animal study.

From a technical standpoint, studies of this kind generally combine standardized stress paradigms with longitudinal metabolomic sampling. Restraint stress, elevated platform exposure, and chronic unpredictable stress are among the common protocols used to elicit measurable HPA axis activation in mice. Blood or plasma samples are collected before stress exposure, during the acute response, and after recovery, allowing researchers to distinguish baseline metabolic state from stress-evoked changes. Samples are then analyzed by liquid chromatography coupled to mass spectrometry, a technique capable of quantifying hundreds of metabolites in small sample volumes. Statistical models, often including machine-learning classifiers, are applied to identify metabolite combinations that predict outcome measures such as corticosterone area under the curve, latency to recover, or behavioral indices of coping style.

The sex-specific framing of the study is its most consequential element. If male and female mice show different metabolic predictors of the same stress outcome, then any biomarker panel derived from pooled data would be misleading, blending distinct sex-specific signatures into an average that describes neither sex well. Sex differences in energy metabolism are well established: females tend to rely more heavily on lipid oxidation, show cyclical variation in metabolic gene expression linked to the estrous cycle, and exhibit different hepatic and adipose responses to glucocorticoids. These physiological differences plausibly shape which metabolites rise and fall during stress and how tightly those changes correlate with hormonal and behavioral readouts. A sex-stratified analytic approach, in which predictive models are built and validated separately within each sex, is the methodologically sound response to this complexity, and the study’s title indicates that such stratification was central to the analysis.

The broader significance of this line of research lies in prediction rather than description. Descriptive studies tell us that stressed animals look metabolically different from unstressed ones; predictive studies ask whether the metabolic state of an animal before stress can foretell how badly it will fare afterward. This distinction matters clinically, because the ultimate goal of biomarker research in psychiatry is to identify vulnerable individuals before illness develops, when preventive interventions are most effective. In mice, identifying pre-stress metabolic signatures that forecast stress sensitivity would provide a tractable model for understanding the biology of vulnerability and resilience, and would generate concrete hypotheses about which pathways, such as mitochondrial function, lipid handling, or amino acid metabolism, underlie individual differences in stress reactivity.

As with all animal research, cautious interpretation is warranted. Metabolic predictors identified in inbred mice under controlled laboratory conditions may not generalize to outbred populations or to humans, whose genetic, dietary, and environmental variability is far greater. Replication across laboratories, strains, and stress paradigms will be essential before any candidate biomarker achieves credibility. Nevertheless, the study exemplifies a methodological shift that is reshaping preclinical stress research: the combination of longitudinal metabolomics, sex-stratified analysis, and predictive modeling, aimed at transforming the study of stress from a purely behavioral science into a quantitative, biologically grounded discipline with genuine translational potential. For a field in which subjective behavioral endpoints have long been the primary currency, the search for sex-aware metabolic predictors of stress responses represents a meaningful step toward precision approaches in stress biology.

Corticosterone itself deserves brief attention, since it is the rodent equivalent of cortisol in humans and is often the first endpoint measured in stress experiments. Its levels rise within minutes of a stressor and can vary with time of day, following circadian rhythms that peak around the onset of the active phase. Researchers therefore standardize sampling times carefully, because a metabolite measured at the circadian peak may behave very differently from the same metabolite measured hours later. This temporal sensitivity extends to the metabolome more broadly, as many circulating lipids and amino acids fluctuate with feeding schedules, gut microbial activity, and sleep-wake cycles, all of which must be controlled for metabolomic findings to be reproducible.

The estrous cycle adds a further layer of complexity in female mice. Unlike humans, mice have a short cycle lasting roughly four to five days, and circulating ovarian hormones can influence both HPA axis reactivity and hepatic metabolism. Some laboratories track cycle stage at the time of sampling, while others rely on large sample sizes to average across stages, and the choice between these strategies remains actively debated. A study explicitly modeling sex differences must confront this variability, and doing so transparently strengthens rather than weakens the resulting conclusions.

Policy developments have also pushed this research direction forward. Since 2016, the National Institutes of Health has required applicants to account for sex as a biological variable in vertebrate animal and human studies, and leading journals have adopted similar expectations. The present study aligns with these standards and illustrates why they matter analytically, not just administratively. When predictive models are trained on pooled sexes, sex-specific signals can partially cancel, degrading performance in ways that are invisible unless stratified analyses are performed.

Finally, the cross-species portability of metabolomic platforms merits emphasis. Mass spectrometry assays developed for mouse plasma can often be run on human serum with minimal modification, allowing candidate predictors identified in animals to be tested directly in patient cohorts. This shared measurement infrastructure is what distinguishes metabolite-based biomarkers from many behavioral or neural measures, which are far harder to align across species, and it underpins the translational ambition of work of this kind.

Subject of Research: Sex-specific metabolic biomarkers of stress responses in adult C57Bl/6 mice

Article Title: Sex specific metabolic predictors of stress responses in adult C57Bl/6 mice

Article References: Rinaudo, M., D’Amelio, C., Natale, F., Ingenito, A., Troisi, J., Spinelli, M., Piacentini, R., Fusco, S., & Grassi, C. (2026). Sex specific metabolic predictors of stress responses in adult C57Bl/6 mice. Translational Psychiatry. https://doi.org/10.1038/s41398-026-04436-1

Image Credits: AI Generated

DOI: 10.1038/s41398-026-04436-1

Keywords: stress response, metabolomics, sex differences, C57Bl/6 mice, HPA axis, corticosterone, translational psychiatry, biomarkers, preclinical research, stress vulnerability, metabolic profile, behavioral neuroscience